| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PRVA | Common Stock, $0.01 par value per share | Options Exercise | $184K | +91.8K | +75.43% | $2.00 | 214K | Aug 15, 2022 | Direct | |
| transaction | PRVA | Common Stock, $0.01 par value per share | Sale | -$3.13M | -86.7K | -40.58% | $36.16 | 127K | Aug 15, 2022 | Direct | F1, F2 |
| transaction | PRVA | Common Stock, $0.01 par value per share | Sale | -$191K | -5.17K | -4.07% | $36.86 | 122K | Aug 15, 2022 | Direct | F1, F3 |
| transaction | PRVA | Common Stock, $0.01 par value per share | Options Exercise | $88.4K | +44.2K | +36.29% | $2.00 | 166K | Aug 16, 2022 | Direct | |
| transaction | PRVA | Common Stock, $0.01 par value per share | Sale | -$1.45M | -41.4K | -24.98% | $34.91 | 124K | Aug 16, 2022 | Direct | F1, F4 |
| transaction | PRVA | Common Stock, $0.01 par value per share | Sale | -$97.5K | -2.74K | -2.2% | $35.60 | 122K | Aug 16, 2022 | Direct | F1, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PRVA | Stock Option (Right to Purchase) | Options Exercise | $0 | -91.8K | -1.84% | $0.00 | 4.91M | Aug 15, 2022 | Common Stock | 91.8K | $2.00 | Direct | F6 |
| transaction | PRVA | Stock Option (Right to Purchase) | Options Exercise | $0 | -44.2K | -0.9% | $0.00 | 4.86M | Aug 16, 2022 | Common Stock | 44.2K | $2.00 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021. |
| F2 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.70 to $36.68 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| F3 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.70 to $37.21 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| F4 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.50 to $35.49 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| F5 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.50 to $35.84 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| F6 | Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 4,110,116 of the stock options were fully vested and exercisable. 890,090 of the stock options vest on October 29, 2022. |